Lightnews — Scholar-powered news

Mireille Kamariza

@kamariza.bsky.social

110 followers 270 following 7 posts

Assistant Professor @ UCLA. Chemical probes, bacterial biology and biochemistry, diagnostics, infectious diseases. Opinions my own.

Posts Media Videos Starter Packs

Mireille Kamariza @kamariza.bsky.social · 1d

I am #recruiting for a postdocs & lab techs to dissect #TB drug resistance using advanced fluorescence #microscopy techniques. Experience in #chemicalbiology #microbiology, #molecularbiology required.

Interested individuals can apply here: lnkd.in/g3nPr8pd

Please share this opportunity widely!

This link will take you to a page that’s not on LinkedIn

lnkd.in

Mireille Kamariza @kamariza.bsky.social · 12d

Come work with me at UCLA!
I’m hiring #postdocs to join my lab where we’re building new tools to detect TB drug resistance using fluorescence microscopy.
If you’ve got a PhD (or soon will) in microbiology/chemical biology - bonus if you’ve worked in BSL3:

👉 Apply: recruit.apo.ucla.edu/JPF10626

Postdoctoral Researcher

University of California, Los Angeles is hiring. Apply now!

recruit.apo.ucla.edu

Reposted by Mireille Kamariza

Megan Ranney MD MPH @meganranney.bsky.social · Jul 9

A small piece of good news in #publichealth today: in addition to malaria vaccines for kids age 5 month+, we now have malaria TREATMENT for babies!

(Of course, we also have to pay for the treatment & make it accessible. But I will take any joy I can find.)

www.washingtonpost.com/health/2025/...

First malaria treatment for newborn babies approved for use

Malaria caused 597,000 deaths worldwide in 2023, with children under 5 accounting for 76 percent of all malaria deaths in the World Health Organization’s Africa region.

www.washingtonpost.com

5 77 270

Reposted by Mireille Kamariza

Mill_lab @cilialab.bsky.social · Jul 7

📣 Cilia Lab is growing 📣 - we have 2️⃣ open positions at @uoe-igc.bsky.social @edinburgh-uni.bsky.social for talented and motivated researchers interested in disease modelling & genetic therapies which target #RareRespiratoryDiseases at their root cause. 🧪🧪#ciliopathies #PrimaryCiliaryDyskinesia 1/4

2 23 28

Reposted by Mireille Kamariza

Jeremy Berg @jeremymberg.bsky.social · Jun 27

New Science story about the beginnings of grant reinstatement.

www.science.org/content/arti...

NIH will reinstate 900 grants in response to court order

Projects touching on sensitive topics such as DEI had been illegally terminated, judge found

www.science.org

4 14 43

Reposted by Mireille Kamariza

Will Ratcliff @wcratcliff.bsky.social · Jun 24

1/27 We have a new paper out! Turns out that snowflake yeast have been hiding a secret from us - they've evolved a (very!) crude circulatory system. Not with blood vessels or a heart, but through spontaneous fluid flows powered by their metabolism. 🧪🔬

www.science.org/doi/full/10....

14 150 360

Mireille Kamariza @kamariza.bsky.social · Jun 25

Thanks! We can get down to ~ 10 cfu/ul if incubated for 3 doubling times (a bit longer for tb since it’s a slow grower). Still faster than plating for cfu!

Mireille Kamariza @kamariza.bsky.social · Jun 25

Obligatory intro post as a Bluesky newbie! 👋 Here’s a recent pic of my lab at UCLA — we’re a fun, curious crew studying antimicrobial resistance and the hidden structures of microbial RNA to fight infectious diseases (especially TB).

Follow along for science, stories, and snapshots from the lab! 🧬🧫

1 7

Mireille Kamariza @kamariza.bsky.social · Jun 25

Working link here! www.biorxiv.org/content/10.1...

7 8

Mireille Kamariza @kamariza.bsky.social · Jun 25

Thx! This link should work: www.biorxiv.org/content/10.1...

Tre-DST: A new drug susceptibility test for Mycobacterium tuberculosis using solvatochromic trehalose probes

Tuberculosis (TB) is the most lethal cause of death from a single infectious agent. In 2024, an estimated 10 million people developed TB, nearly half a million of which were infected with drug-resista...

www.biorxiv.org

1 2

Mireille Kamariza @kamariza.bsky.social · Jun 25

First BlueSky post to share that the First #preprint from the Kamariza Lab is live! We develop a trehalose-based assay to report drug resistance in Mycobacterium #tuberculosis. Check it out on bioRxiv: biorxiv.org/content/10.110…
#TBT#diagnosticic

https://biorxiv.org/content/10.110…

1 5 14